ライフサイエンスコーパス: Pseudomonas aeruginosa

1 ic bacteria (e.g., Staphylococcus aureus and Pseudomonas aeruginosa).

2 positive Bacillus subtilis and Gram-negative Pseudomonas aeruginosa.

3 natural bispecific IgG1 candidate, targeting Pseudomonas aeruginosa.

4 ctamases, but is considered inactive against Pseudomonas aeruginosa.

5 duced and expressed in the outer membrane of Pseudomonas aeruginosa.

6 inhibits QS in opportunistic human pathogen Pseudomonas aeruginosa.

7 (ETA) is the most toxic virulence factor of Pseudomonas aeruginosa.

8 Paulo MBL (SPM-1) from beta-lactam-resistant Pseudomonas aeruginosa.

9 ic cells of the opportunistic human pathogen Pseudomonas aeruginosa.

10 ulence factors in the opportunistic pathogen Pseudomonas aeruginosa.

11 amma agonists attenuate biofilm formation by Pseudomonas aeruginosa.

12 ross some bacteria including Vibrio spp. and Pseudomonas aeruginosa.

13 omising therapeutic antibody targets against Pseudomonas aeruginosa.

14 ceftazidime-resistant Enterobacteriaceae or Pseudomonas aeruginosa.

15 jugation, and maintained in K pneumoniae and Pseudomonas aeruginosa.

16 MDR) gram-negative bacteria (GNB), including Pseudomonas aeruginosa.

17 fection assays with the pathogenic bacterium Pseudomonas aeruginosa.

18 nsors to trigger acute virulence programs in Pseudomonas aeruginosa.

19 olonisation by respiratory pathogens such as Pseudomonas aeruginosa.

20 ould be maintained when tested on pathogenic Pseudomonas aeruginosa.

21 ignature analysis for the bacterial pathogen Pseudomonas aeruginosa.

22 nescent strains of Staphylococcus aureus and Pseudomonas aeruginosa.

23 abolite by the opportunistic human pathogen, Pseudomonas aeruginosa.

24 e-associated pyochelin siderophore system in Pseudomonas aeruginosa.

25 m antibiotics in many Enterobacteriaceae and Pseudomonas aeruginosa.

26 e mass spectra of membrane grown biofilms of Pseudomonas aeruginosa.

27 le and cultures of Aspergillus fumigatus and Pseudomonas aeruginosa.

28 h a unique species-specific activity against Pseudomonas aeruginosa.

29 Staphylococcus aureus (12.9%) and Pseudomonas aeruginosa (11.5%) were the most common path

30 s (MRSA) and Candida albicans) and standard (Pseudomonas aeruginosa 15692) pathogens.

31 for the majority of Gram negative bacteria (Pseudomonas aeruginosa, 16-32 mug/mL, Klebsiella pneumon

32 broth microdilution (BMD) for 99 isolates of Pseudomonas aeruginosa, 26 Acinetobacter baumannii isola

33 (n=355) were Klebsiella pneumoniae (37%) and Pseudomonas aeruginosa (30%); 28% were ceftazidime-non-s

34 tive Staphylococcus aureus and gram-negative Pseudomonas aeruginosa (99.3 +/- 1.9% and 88.5 +/- 3.3%

35 We used the bacterium Pseudomonas aeruginosa, a common cause of hospital-acqui

36 at are notoriously problematic in hospitals: Pseudomonas aeruginosa, Acinetobacter baumannii, and Sta

37 lostridium difficile, Staphylococcus aureus, Pseudomonas aeruginosa, Acinetobacter baumannii, carbape

38 Carbapenem-resistant Pseudomonas aeruginosa, Acinetobacter spp., and Enteroba

39 Pseudomonas aeruginosa acquires extracellular heme via t

40 by the Gram-negative opportunistic pathogen, Pseudomonas aeruginosa Activation of phospholipase activ

41 Pseudomonas aeruginosa adaptation to survive in the host

42 healthy mouse corneas becomes vulnerable to Pseudomonas aeruginosa adhesion if it lacks the innate d

43 n was spliced into a poly-HAMP unit from the Pseudomonas aeruginosa Aer2 receptor.

44 s this question in the pathogenic bacterium, Pseudomonas aeruginosa Although public goods producers w

45 gainst experimental endocarditis (EE) due to Pseudomonas aeruginosa, an archetype of difficult-to-tre

46 non-glucose-fermenting Gram-negative bacilli Pseudomonas aeruginosa and Acinetobacter baumannii are i

47 bial performance against two MDR isolates of Pseudomonas aeruginosa and Acinetobacter baumannii throu

48 ing Gram-negative bacilli (CPNFs), including Pseudomonas aeruginosa and Acinetobacter baumannii, is n

49 erved against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii.

50 and model drug by LPS from F. tularensis vs Pseudomonas aeruginosa and by F. tularensis live bacteri

51 epresented species in the tumors followed by Pseudomonas aeruginosa and Campylobacter sp.

52 Structures of Lnt from Pseudomonas aeruginosa and Escherichia coli have been so

53 coccus pyogenes) and gram-negative bacteria (Pseudomonas aeruginosa and Escherichia coli) over time t

54 ic strains including Neisseria meningitidis, Pseudomonas aeruginosa and Escherichia coli.

55 n of biofilms formed by the mucoid strain of Pseudomonas aeruginosa and investigated the commonality

56 is synthesized by the opportunistic pathogen Pseudomonas aeruginosa and is an important biofilm const

57 ed reservoirs, including electronic faucets (Pseudomonas aeruginosa and Legionella), decorative water

58 as Escherichia coli, Enterobacter aerogenes, Pseudomonas aeruginosa and Salmonella Typhimurium The ge

59 ocystitis; Coagulase negative Staphylococci, Pseudomonas aeruginosa and Staphylococcus aureus in kera

60 PPH assay and antibacterial activity against Pseudomonas aeruginosa and Staphylococcus aureus was ass

61 rial activity of raw rapeseed honeys against Pseudomonas aeruginosa and Staphylococcus aureus, with a

62 extran-coated nanoceria was examined against Pseudomonas aeruginosa and Staphylococcus epidermidis by

63 red by new data from 28 clinical isolates of Pseudomonas aeruginosa and strains evolved in laboratory

64 ough horizontal gene transfer by the species Pseudomonas aeruginosa and subsequently abundant P. aeru

65 opportunistic pathogens, namely the bacteria Pseudomonas aeruginosa and the fungus Aspergillus fumiga

66 obal sRNA interactions with their targets in Pseudomonas aeruginosa and verified the method with a kn

67 Escherichia coli, Staphylococcus aureus and Pseudomonas aeruginosa) and in vitro anti-proliferative

68 ith 294 isolates of Enterobacteriaceae spp., Pseudomonas aeruginosa, and Acinetobacter baumannii chos

69 (Staphylococcus aureus, Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii).

70 nslational modification in Escherichia coli, Pseudomonas aeruginosa, and Bacillus subtilis.

71 apenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa, and carbapenem-resistant and thi

72 lococcus epidermidis, Enterococcus faecalis, Pseudomonas aeruginosa, and Klebsiella pneumoniae, which

73 ria-Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, and mycobacteria.

74 c bacterial strains: Legionella pneumophila, Pseudomonas aeruginosa, and Salmonella typhimurium.

75 way infections by the opportunistic pathogen Pseudomonas aeruginosa are a major cause of mortality in

76 he fungus Candida albicans and the bacterium Pseudomonas aeruginosa are coisolated in the context of

77 Staphylococci, Streptococcus pneumoniae and Pseudomonas aeruginosa are the leading isolates in ocula

78 Using Pseudomonas aeruginosa as a model system, the authors sh

79 to Escherichia coli, Klebsiella species, or Pseudomonas aeruginosa at 130 VHA facilities from Januar

80 between the two domains and is able to kill Pseudomonas aeruginosa at sub-micromolar concentrations.

81 the study was to assess the applicability of Pseudomonas aeruginosa ATCC9027 and its validated biolum

82 olate bond in an engineered copper centre in Pseudomonas aeruginosa azurin by rational design of the

83 li, Salmonella enterica serovar Typhimurium, Pseudomonas aeruginosa, Bacillus subtilis, and Staphyloc

84 l toxic epidermal necrolysis with concurrent Pseudomonas aeruginosa bacteraemia.

85 olymicrobial, with Staphylococcus aureus and Pseudomonas aeruginosa being the two most commonly isola

86 plant metabolites called flavonoids inhibit Pseudomonas aeruginosa biofilm formation by an unknown m

87 rophage migration inhibitory factor enhances Pseudomonas aeruginosa biofilm formation, potentially co

88 Pseudomonas aeruginosa biofilm infections are difficult

89 ion yellow 11), which targets amyloid in the Pseudomonas aeruginosa biofilm matrix through a diversit

90 ial transcriptome map of the mature in vitro Pseudomonas aeruginosa biofilm model, revealing contempo

91 This paper studies the formation of a Pseudomonas aeruginosa biofilm on a Papyex graphite (PA)

92 We established a new approach to study Pseudomonas aeruginosa biofilm susceptibility on biotic

93 d healing, wild-type mice were infected with Pseudomonas aeruginosa biofilms and, akin to Nod2(-/-) m

94 alize protein and metal distributions within Pseudomonas aeruginosa biofilms using imaging mass spect

95 on interact to shape competitive dynamics in Pseudomonas aeruginosa biofilms.

96 Moreover, Pseudomonas aeruginosa BioH is more highly expressed tha

97 ated the best antibacterial activity against Pseudomonas aeruginosa both in vitro and in vivo for tet

98 We describe for the first time how Pseudomonas aeruginosa can utilize human recombinant MIF

99 The N-acetylglucosaminidase NagZ of Pseudomonas aeruginosa catalyzes the first cytoplasmic s

100 Pseudomonas aeruginosa causes hospital-acquired pneumoni

101 that enables cross-species interactions, as Pseudomonas aeruginosa cells also become attracted to th

102 ng approximately 90% of Escherichia coli and Pseudomonas aeruginosa cells within 90-120 and 5-30 min,

103 face glycosylation is modulated by IL-1R and Pseudomonas aeruginosa challenge but is insufficient for

104 vations link respiratory virus infection and Pseudomonas aeruginosa colonization in chronic lung dise

105 ophilia and mucin production associated with Pseudomonas aeruginosa colonization, which is associated

106 we report the crystal structure of LspA from Pseudomonas aeruginosa complexed with the antimicrobial

107 ng of a genetically detoxified exotoxin A of Pseudomonas aeruginosa covalently linked to Shigella fle

108 for the detection of carbapenemase-producing Pseudomonas aeruginosa (CP-PA) and carbapenemase-produci

109 ne conductance regulator (CFTR) that reduces Pseudomonas aeruginosa culture positivity in CF patients

110 Pseudomonas aeruginosa defies eradication by antibiotics

111 Ivacaftor produced rapid decreases in sputum Pseudomonas aeruginosa density that began within 48 hour

112 actively synthesized proteins in nongrowing Pseudomonas aeruginosa, discovering a regulator whose in

113 reted components by the pathogenic bacterium Pseudomonas aeruginosa during growth on a protein substr

114 e rate by human neutrophil elastase (NE) and Pseudomonas aeruginosa elastase (PAE) by different mecha

115 The nefarious Gram-negative pathogen Pseudomonas aeruginosa encodes eleven LTs.

116 ysts of intracellular phenazine reduction in Pseudomonas aeruginosa Enzymatic assays in cell-free lys

117 thal toxin, diphtheria toxin, cholera toxin, Pseudomonas aeruginosa exotoxin A, Botulinum neurotoxin,

118 Strains of the opportunistic pathogen Pseudomonas aeruginosa express one of five different typ

119 large, non-Nocardia, or classically invasive Pseudomonas aeruginosa; for patients with low baseline v

120 The opportunistic pathogen Pseudomonas aeruginosa forms antimicrobial resistant bio

121 ic coinfections of Staphylococcus aureus and Pseudomonas aeruginosa frequently fail to respond to ant

122 f Enterobacteriaceae, Acinetobacter spp, and Pseudomonas aeruginosa from 18 698 inpatients and 2923 h

123 ce variant of PTEN, were unable to eradicate Pseudomonas aeruginosa from the airways and could not ge

124 A) plays a critical role in the clearance of Pseudomonas aeruginosa from the lung.

125 n B addition engendered Escherichia coli and Pseudomonas aeruginosa Gram-negative activity MIC's of 4

126 r interface and the active sites can abolish Pseudomonas aeruginosa growth in a defined medium with m

127 t of EGCG against the opportunistic pathogen Pseudomonas aeruginosa has been shown to involve disrupt

128 The Gram-negative pathogen Pseudomonas aeruginosa has three T6SSs involved in colon

129 nization with other pathogens, in particular Pseudomonas aeruginosa Here, we demonstrate that CF mice

130 For Pseudomonas aeruginosa, human monoclonal antibodies (mAb

131 )F-fluoromaltotriose was also able to detect Pseudomonas aeruginosa in a clinically relevant mouse mo

132 ge therapy for acute pneumonia caused by MDR Pseudomonas aeruginosa in a mouse model.

133 de Staphylococci, Streptococcus pyogenes and Pseudomonas aeruginosa in blepharitis; Staphylococci, St

134 mune responses in non-neural tissues against Pseudomonas aeruginosa in Caenorhabditis elegans.

135 apid, redox-active biomarker for identifying Pseudomonas aeruginosa in clinical infections.

136 had lower sensitivities for the detection of Pseudomonas aeruginosa in comparison to the analogous 7-

137 red to those to the well-studied CF pathogen Pseudomonas aeruginosa In parallel, mice were also infec

138 strain of Escherichia coli to sense and kill Pseudomonas aeruginosa in vitro.

139 fabricated an immunosensor for detection of Pseudomonas aeruginosa in water.

140 utrophil synthesis of LTB4 in the context of Pseudomonas aeruginosa-induced neutrophil transepithelia

141 induced in mouse macrophages in response to Pseudomonas aeruginosa infection both in vivo and by iso

142 LPS treatment or Pseudomonas aeruginosa infection induces miR-301b expres

143 Pseudomonas aeruginosa infection liberates transmissible

144 tactic gradients, and migrate in response to Pseudomonas aeruginosa infection of primary ALI barriers

145 leus, histamine blocker use, and respiratory Pseudomonas aeruginosa infection were associated with lo

146 p=0.037) when adjusted for sex, BMI, chronic Pseudomonas aeruginosa infection, FEV1/FVC (forced vital

147 the eye from pathogenic Candida albicans or Pseudomonas aeruginosa infection.

148 t poly(I:C), improved the host response to a Pseudomonas aeruginosa infection.

149 rse outcomes, particularly in the setting of Pseudomonas aeruginosa infection.

150 (KO) mice with aerosolized LPS (100 mug) or Pseudomonas aeruginosa infection.

151 resistance during multidrug resistant (MDR)-Pseudomonas aeruginosa infections are limited.

152 rventions to treat multidrug-resistant (MDR) Pseudomonas aeruginosa infections are severely limited a

153 Recurrent Pseudomonas aeruginosa infections coupled with robust, d

154 Pseudomonas aeruginosa is a Gram-negative bacterial path

155 Pseudomonas aeruginosa is a Gram-negative opportunistic

156 Pseudomonas aeruginosa is a Gram-negative, opportunistic

157 Pseudomonas aeruginosa is a leading cause of hospital-ac

158 Pseudomonas aeruginosa is a leading cause of nosocomial

159 The opportunistic pathogen Pseudomonas aeruginosa is a major cause of sepsis in sev

160 Pseudomonas aeruginosa is a major cause of severe infect

161 Pseudomonas aeruginosa is a pathogenic gram-negative org

162 Pseudomonas aeruginosa is a significant contributor to r

163 Pseudomonas aeruginosa is a ubiquitous environmental org

164 Pseudomonas aeruginosa is among the leading causes of se

165 Pseudomonas aeruginosa is an important opportunistic hum

166 Pseudomonas aeruginosa is an opportunistic and frequentl

167 Pseudomonas aeruginosa is an opportunistic pathogen that

168 The ubiquitous bacterium Pseudomonas aeruginosa is an opportunistic pathogen that

169 and characterization of 20 muropeptides from Pseudomonas aeruginosa is described.

170 nsporter FpvAI in the opportunistic pathogen Pseudomonas aeruginosa is hijacked to translocate the ba

171 The pathogenic profile of Pseudomonas aeruginosa is related to its ability to secr

172 demonstrate that the Gram-negative pathogen Pseudomonas aeruginosa is susceptible to reactive oxygen

173 -GMP signaling in the opportunistic pathogen Pseudomonas aeruginosa is the transcription regulator Fl

174 resolution, we show that granule genesis in Pseudomonas aeruginosa is tightly organized under nitrog

175 ation with bacterial pathogens, particularly Pseudomonas aeruginosa, is the primary cause of morbidit

176 the time to detection (TTD) and growth of 2 Pseudomonas aeruginosa isolates in the presence of clini

177 robacteriaceae, Acinetobacter baumannii, and Pseudomonas aeruginosa isolates.

178 ecretion system effector found in 90% of the Pseudomonas aeruginosa isolates.

179 For Pseudomonas aeruginosa, it has long been known that intr

180 accounts for biofilm-mediated resistance to Pseudomonas aeruginosa killing.

181 ria are Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa, Klebsiella pneumonia.

182 tis; Staphylococci, Streptococus pneumoniae, Pseudomonas aeruginosa, Klebsiella pneumoniae and Escher

183 Pseudomonas aeruginosa lacking the Pseudomonas prolyl-hy

184 ghput to sequence approximately 400 clinical Pseudomonas aeruginosa libraries and demonstrate excelle

185 aling activity of Hfq from Escherichia coli, Pseudomonas aeruginosa, Listeria monocytogenes, Bacillus

186 Infections by multidrug-resistant Pseudomonas aeruginosa (MDRPa) are an important cause of

187 built here an intact atomistic model of the Pseudomonas aeruginosa MexAB-OprM pump in a Gram-negativ

188 Here we defined PF orthologs in Pseudomonas aeruginosa, Moraxella catarrhalis, and Staph

189 Pseudomonas aeruginosa move across surfaces by using mul

190 A Pseudomonas aeruginosa mutant lacking all three known ir

191 ) from E. coli B, E. coli 056, E. coli 0111, Pseudomonas aeruginosa NBRC 13743 and Hafnia alvei 1185.

192 nfections such as invasive aspergillosis and Pseudomonas aeruginosa occurred during hospitalization.

193 Growth of Pseudomonas aeruginosa on spermine requires a functional

194 In Pseudomonas aeruginosa, one of the best studied models f

195 fluorescent pseudomonads, such as pathogenic Pseudomonas aeruginosa or plant growth-promoting Pseudom

196 receptor, was induced by infection with live Pseudomonas aeruginosa or treatment of cells with its su

197 ne reproductive pathogens (Escherichia coli, Pseudomonas aeruginosa, or Klebsiella pneumoniae) isolat

198 trains including Escherichia coli (E. coli), Pseudomonas aeruginosa (P. aeruginosa), Staphylococcus a

199 n-resistant Sthaphylococcus aureus, MRSA and Pseudomonas aeruginosa, P. aeruginosa) were analyzed in

200 Pseudomonas aeruginosa (PA) is a ubiquitous microbe.

201 Pseudomonas aeruginosa (PA) remains an important pathoge

202 ycobacterium marinum (Mm) (a model for Mtb), Pseudomonas aeruginosa (Pa), Legionella pneumophila (Lp)

203 Pseudomonas aeruginosa(Pa) was present in CF sputum in 1

204 dox-active phenazine metabolites produced by Pseudomonas aeruginosa PA14 colony biofilms.

205 Here, we show that the bacterium Pseudomonas aeruginosa PA14 uses the cell-cell communica

206 In the pathogenic bacterium Pseudomonas aeruginosa PA14, antibiotics called phenazin

207 e, we identified a tRNA methyltransferase in Pseudomonas aeruginosa PA14, trmJ, which confers resista

208 nd respiration in the opportunistic pathogen Pseudomonas aeruginosa PA14.

209 he type I-F CRISPR adaptive immune system in Pseudomonas aeruginosa (PA14) consists of two CRISPR loc

210 g protein (PumA) of the multi-drug resistant Pseudomonas aeruginosa PA7 strain.

211 The responses of Pseudomonas aeruginosa PAO1 and PA14 to a hexadecane-wat

212 The textile MFC used Pseudomonas aeruginosa PAO1 as a biocatalyst to generate

213 receptors and a single chemosensory pathway, Pseudomonas aeruginosa PAO1 has a much more complex chem

214 aves B-band LPS (O-specific antigen, OSA) of Pseudomonas aeruginosa PAO1.

215 tailed bacterial viruses, or phages, such as Pseudomonas aeruginosa phage varphiKZ, have long genomes

216 Phis are hyperinflammatory and have impaired Pseudomonas aeruginosa phagocytosis, phenocopying CF MPh

217 Pseudomonas aeruginosa populations undergo a characteris

218 mp MexGHI-OpmD in the opportunistic pathogen Pseudomonas aeruginosa Previous studies of P. aeruginosa

219 The opportunistic pathogen Pseudomonas aeruginosa produces colorful redox-active me

220 Pseudomonas aeruginosa produces increased levels of algi

221 The opportunistic pathogen Pseudomonas aeruginosa produces the cationic exopolysacc

222 This cascade consists of four Pseudomonas aeruginosa protein regulators (ExsADCE) that

223 e, the authors show that two DMAbs targeting Pseudomonas aeruginosa proteins confer protection agains

224 ontaining phosphodiesterase domains from the Pseudomonas aeruginosa proteins PA3825 (PA3825(EAL)) and

225 The outer membrane protein H (OprH) of Pseudomonas aeruginosa provides an increased stability t

226 arothermophilus) and gram-negative bacteria (Pseudomonas aeruginosa, Pseudomonas fluorescens, Salmone

227 al factors governing this critical period in Pseudomonas aeruginosa pulmonary pathogenesis when trans

228 y identified NB predicted to be specific for Pseudomonas aeruginosa (pyocin Sn) was produced and show

229 Analysis of a Pseudomonas aeruginosa quiC1 gene knock-out demonstrates

230 -heptyl-4-hydroxyquinoline-N-oxide (HQNO), a Pseudomonas aeruginosa quorum-sensing-regulated low-mole

231 Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa) relative to controls.

232 Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa-reported here underscores the bro

233 hicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa, respectively, in catheter-associ

234 tunistic pathogens Aspergillus fumigatus and Pseudomonas aeruginosa, respectively.

235 interactions with the respiratory pathogens Pseudomonas aeruginosa, respiratory syncytial virus and

236 co-infection of murine surgical wounds with Pseudomonas aeruginosa results in conversion of approxim

237 Exposure to a bacterial pathogen (Pseudomonas aeruginosa) results in elevated removal of u

238 inding sites of the RNase E component of the Pseudomonas aeruginosa RNA degradosome, occluding them f

239 EF-Tu from the clinically relevant pathogen Pseudomonas aeruginosa shares over 84% sequence identity

240 Our functional studies in Pseudomonas aeruginosa show that its two-subunit PC is i

241 posed to include Acinetobacter baumannii and Pseudomonas aeruginosa (SNAP and POP studies).

242 Here we show that Pseudomonas aeruginosa specific bacteriocins, known as p

243 ith Escherichia coli, Enterococcus faecalis, Pseudomonas aeruginosa, Staphylococcus aureus (including

244 netobacter baumannii, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus, and coagu

245 ebsiella pneumoniae, Legionella pneumophila, Pseudomonas aeruginosa, Stenotrophomonas maltophilia, Vi

246 me-scale metabolic network reconstruction of Pseudomonas aeruginosa strain PA14 and an updated, expan

247 sted the individual oxidants on the virulent Pseudomonas aeruginosa strain PA14.

248 and metabolism (oprB, gltK, gtrS and glk) in Pseudomonas aeruginosa, strain PAO1.

249 We demonstrate that the pathogenicity of Pseudomonas aeruginosa strains derived from acute clinic

250 ix mares were inoculated with lux-engineered Pseudomonas aeruginosa strains isolated from equine uter

251 We used a collection of well characterized Pseudomonas aeruginosa strains, featuring distinct antib

252 N prevented death due to pneumonia caused by Pseudomonas aeruginosa, Streptococcus pneumoniae, and As

253 to a burn infected with multidrug-resistant Pseudomonas aeruginosa substantially decreased bacterial

254 ative organisms with higher activity towards Pseudomonas aeruginosa than the naturally-occurring AMP

255 In other genomes such as Pseudomonas aeruginosa the bioH gene is within a biotin

256 faucets were most frequently colonized, and Pseudomonas aeruginosa the predominant organism.

257 olution X-ray crystal structure of FliD from Pseudomonas aeruginosa, the first high-resolution struct

258 In Pseudomonas aeruginosa, the Pil-Chp system regulates T4P

259 bound to the MLPs from Escherichia coli and Pseudomonas aeruginosa These new structures, along with

260 ubiquitous and opportunistic human pathogen Pseudomonas aeruginosa This bacterium is frequently adop

261 a chemotaxis-regulating methyltransferase in Pseudomonas aeruginosa This cocrystal structure, togethe

262 For the pathogen Pseudomonas aeruginosa, this evasion appears to be trigg

263 trate a 5-log increase in the sensitivity of Pseudomonas aeruginosa to ciprofloxacin.

264 s by RNA-Seq to characterize the response of Pseudomonas aeruginosa to external 0.5 mm CuSO4, a condi

265 Here, we experimentally evolved Pseudomonas aeruginosa to six 2-drug sequences.

266 tudying the sensitivities of a ohr mutant of Pseudomonas aeruginosa toward different hydroperoxides.

267 ulence factors for many pathogens, including Pseudomonas aeruginosa Transcription of the major pilin

268 Pseudomonas aeruginosa translocators PopB and PopD inser

269 The Pseudomonas aeruginosa type III secretion system deliver

270 lus also are dispensable for activation of a Pseudomonas aeruginosa type VI secretion system (T6SS).

271 The adaptive immune system in Pseudomonas aeruginosa (type I-F) relies on a 350 kDa CR

272 and gene essentiality in the model organism Pseudomonas aeruginosa UCBPP-PA14.

273 ion of the peptide siderophore pyoverdine by Pseudomonas aeruginosa, under different nutrient-limitin

274 activity developed either an E. faecalis or Pseudomonas aeruginosa urinary tract infection, suggesti

275 Bacteria such as Pseudomonas aeruginosa use type IV pili to move across s

276 la via trophic transfer from bacterial prey (Pseudomonas aeruginosa) versus direct uptake from growth

277 ce in the opportunistic pathogenic bacterium Pseudomonas aeruginosa via an unknown pathway.

278 The discovery of therapies that modulate Pseudomonas aeruginosa virulence or that can eradicate c

279 augments host defense in sepsis and reduces Pseudomonas aeruginosa virulence through quorum sensing

280 In Pseudomonas aeruginosa, virulence is induced with releas

281 nd mediators produced by pyocyanin-producing Pseudomonas aeruginosa (WACC 91) culture.

282 human airway epithelial cells infected with Pseudomonas aeruginosa was applied to lung fibroblasts a

283 Aspergillus flavus and meropenem due to the Pseudomonas aeruginosa was initiated, the former necessi

284 ior of 2707 HDSS caused by the marine aerobe Pseudomonas aeruginosa was investigated.

285 corneal epithelial barrier function against Pseudomonas aeruginosa was MyD88-dependent.

286 Pseudomonas aeruginosa was the only Gram negative bacter

287 ion by other uropathogens (Escherichia coli, Pseudomonas aeruginosa) was also explored, and thioridaz

288 compared with that of its ortholog LecA from Pseudomonas aeruginosa We also investigated the utility

289 ococcus faecalis, Klebsiella pneumoniae, and Pseudomonas aeruginosa We therefore conclude that the un

290 Using PrrF1, an iron-regulated sRNA in Pseudomonas aeruginosa, we demonstrated that direct regu

291 Staphylococcus aureus, Escherichia coli, and Pseudomonas aeruginosa were tested in triplicate using t

292 Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa were the most common isolates.

293 old the minimal inhibitory concentration for Pseudomonas aeruginosa) were compared between the two gr

294 me organisms, such as Klebsiella species and Pseudomonas aeruginosa, were lower in oncology than in n

295 carbapenem-resistant Enterobacteriaceae and Pseudomonas aeruginosa, which are difficult to treat.

296 vae are highly susceptible to infection with Pseudomonas aeruginosa, which can be almost fully rescue

297 patients infected with carbapenem-resistant Pseudomonas aeruginosa who were treated with ceftolozane

298 tified here melanogenic clinical isolates of Pseudomonas aeruginosa with large chromosomal deletions

299 erimentally evolved replicate populations of Pseudomonas aeruginosa with or without a community of th

300 ride, showed efficient biofilm inhibition of Pseudomonas aeruginosa without impairing its growth.